Asarpota Rajesh — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Asarpota Rajesh has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Rajesh Asarpota is a director of Profusa, Inc., a clinical-stage digital health and medical technology company focused on biosensing to improve patient outcomes. The most recent SEC filing for Profusa (CIK 0001600301, dated 2026-01-29) lists him as a director with no reported securities purchases or sales, indicating a governance role rather than an active trading activity in that period. In his capacity as a Profusa board member, he contributes to oversight of the company’s biosensing platform and related strategic initiatives, including products like the Lumee Oxygen offering.
Role
Chief Financial Officer
Notability
28/100
Board memberships
Profusa, Inc.
Awards & honors
Serves as a director on Profusa, Inc.'s board.
Provides governance oversight for Profusa's biosensing platform and clinical development strategy.
Rajesh Asarpota is a director of Profusa, Inc., a clinical-stage digital health and medical technology company focused on biosensing to improve patient outcomes. The most recent SEC filing for Profusa (CIK 0001600301, dated 2026-01-29) lists him as a director with no reported securities purchases or sales, indicating a governance role rather than an active trading activity in t…
How many SEC Form 4 filings has Asarpota Rajesh submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Asarpota Rajesh's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
